Shares of ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) were down 1.9% during mid-day trading on Tuesday . The company traded as low as $3.77 and last traded at $4.03. Approximately 3,329 shares traded hands during trading, a decline of 97% from the average daily volume of 99,556 shares. The stock had previously closed at $4.11.
ENDRA Life Sciences Trading Down 1.9 %
The firm has a market capitalization of $2.16 million, a PE ratio of 0.00 and a beta of 0.43. The business has a 50 day moving average price of $4.89 and a 200-day moving average price of $6.33.
ENDRA Life Sciences Company Profile
ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
Featured Stories
- Five stocks we like better than ENDRA Life Sciences
- Election Stocks: How Elections Affect the Stock Market
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Must-Own Stocks to Build Wealth This Decade
- 3 Healthcare Dividend Stocks to Buy
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
